Neural Network and Physiological Parameters Based Control of Artificial Pancreas for Improved Patient Safety
暂无分享,去创建一个
[1] Insup Lee,et al. Medical Cyber Physical Systems , 2010, Design Automation Conference.
[2] Jiming Chen,et al. Continuous Drug Infusion for Diabetes Therapy: A Closed-Loop Control System Design , 2008, EURASIP J. Wirel. Commun. Netw..
[3] J. Leahy,et al. Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas , 2008 .
[4] P. Cryer,et al. Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes* , 2002, Diabetologia.
[5] F. Chee,et al. Simulation study on automatic blood glucose control , 2001, The Seventh Australian and New Zealand Intelligent Information Systems Conference, 2001.
[6] S. Kahn,et al. Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds. , 2000, Diabetes care.
[7] Andrey V. Savkin,et al. Optimal H∞ insulin injection control for blood glucose regulation in diabetic patients , 2005, IEEE Trans. Biomed. Eng..
[8] J. Zeitlhofer,et al. Monitoring set-up for selection of parameters for detection of hypoglycaemia in diabetic patients , 2007, Medical and Biological Engineering and Computing.
[9] B. Bequette. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.
[10] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[11] H. Nguyen,et al. Real-time detection of nocturnal hypoglycemic episodes using a novel non-invasive hypoglycemia monitor , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[12] A. El-Jabali. Neural network modeling and control of type 1 diabetes mellitus , 2005, Bioprocess and biosystems engineering.
[13] R. Hintsche,et al. Computer-aided continuous drug infusion: setup and test of a mobile closed-loop system for the continuous automated infusion of insulin , 2006, IEEE Transactions on Information Technology in Biomedicine.
[14] J. B. Collip,et al. Pancreatic extracts in the treatment of diabetes mellitus: preliminary report. 1922. , 1991, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[15] Roman Hovorka,et al. Closing the loop: the adicol experience. , 2004, Diabetes technology & therapeutics.
[16] R. Bellazzi,et al. The subcutaneous route to insulin-dependent diabetes therapy. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.
[17] Jefferson Luiz Brum Marques,et al. Altered ventricular repolarization during hypoglycaemia in patients with diabetes , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[18] David C Klonoff,et al. The Artificial Pancreas: How Sweet Engineering Will Solve Bitter Problems , 2007, Journal of diabetes science and technology.
[19] Hiok Chai Quek,et al. A personalized approach to insulin regulation using brain-inspired neural sematic memory in diabetic glucose control , 2007, 2007 IEEE Congress on Evolutionary Computation.
[20] E Renard,et al. Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. , 2006, Diabetes & metabolism.
[21] S R Heller,et al. Physiological disturbances in hypoglycaemia: effect on subjective awareness. , 1991, Clinical science.
[22] R. Bergman,et al. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.
[23] Enrique J. Gómez,et al. The INCA System: A Further Step Towards a Telemedical Artificial Pancreas , 2008, IEEE Transactions on Information Technology in Biomedicine.
[24] Francis J. Doyle,et al. Run-to-run control of blood glucose concentrations for people with type 1 diabetes mellitus , 2006, IEEE Transactions on Biomedical Engineering.
[25] Roman Hovorka,et al. The future of continuous glucose monitoring: closed loop. , 2008, Current diabetes reviews.
[26] Efstratios N. Pistikopoulos,et al. Model-based blood glucose control for type 1 diabetes via parametric programming , 2006, IEEE Transactions on Biomedical Engineering.
[27] W. Kenneth Ward,et al. A Review of Closed-Loop Algorithms for Glycemic Control in the Treatment of Type 1 Diabetes , 2009, Algorithms.
[28] Nicholas A Peppas,et al. The future of open‐ and closed‐loop insulin delivery systems , 2008, The Journal of pharmacy and pharmacology.
[29] W. Kenneth Ward,et al. Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes , 2010, Diabetes Care.
[30] Heikki V Huikuri,et al. Effects of sustained insulin-induced hypoglycemia on cardiovascular autonomic regulation in type 1 diabetes. , 2005, Diabetes.
[31] R. Hovorka. Continuous glucose monitoring and closed‐loop systems , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[32] R S Parker,et al. The intravenous route to blood glucose control. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.